Skip to main content

Romina Dieli Crimi

Institutions of which they are part

Translational Immunology
Vall Hebron Institut de Recerca

Romina Dieli Crimi

Institutions of which they are part

Translational Immunology
Vall Hebron Institut de Recerca

Projects

Modelo predictivo del riesgo de infección y rechazo después del trasplante renal basado en la combinadición de parámetros clínicos y biomarcadores.

IP: Francesc Moreso Mateos
Collaborators: Joana Sellarés Roig, Concepció Jacobs Cachá, Modelo predictivo del riesgo de infección y rechazo después del trasplante renal basado en la combinadición de parámetros clínic, Manel Perelló Carrascosa, Romina Dieli Crimi, Nestor Gabriel Toapanta Gaibor, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI18/01832
Duration: 01/01/2019 - 31/12/2022

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

Related professionals

Mª Teresa Fernández Taranilla

Mª Teresa Fernández Taranilla

Administration and Management
Cardiovascular Diseases
Read more
Albert Selva O'Callaghan

Albert Selva O'Callaghan

Main researcher
Systemic Diseases
Read more
Anna Vilarrodona Serrat

Anna Vilarrodona Serrat

Main researcher
Donation and transplantation of organs, tissues and cells
Read more
M Jesus Arevalo  Navines

M Jesus Arevalo Navines

Postdoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.